ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: TH-PO1132

Presence of Renal Dysfunction Even at the Time of Listing Predicts Risk of ESRD in Isolated Heart Transplant Patients

Session Information

Category: Transplantation

  • 1902 Transplantation: Clinical

Authors

  • Kumar, Abhishek, University of Vermont, Burlington, Vermont, United States
  • Thomas, Christie P., University of Iowa, Iowa City, Iowa, United States
Background

Presence of chronic kidney disease (CKD) at the time of heart transplant is an independent predictor of post-transplant ESRD (end stage renal disease) and all-cause mortality. We wished to look at the effect of the presence and severity of CKD at the time of listing on post-heart transplant ESRD and mortality.

Methods

We analyzed 2000-2015 UNOS heart transplant data. Adults receiving first isolated heart transplant, who were not on dialysis were included in study. We divided our cohort into four clinically relevant groups based on their listing eGFR (<30 ml/min, 30-44 ml/min, 45-59 ml/min and ≥60 ml/min). Survival analysis was used to generate Kaplan-Meier curves. Results were adjusted for multiple confounding factors.

Results

We had 27,169 patients in our cohort. In the follow up period there were 7595 deaths and 2335 patients reached ESRD (Table 1). Kaplan-Meier curves for ESRD are shown in Figure 1.

Conclusion

Our findings shows that risk of renal replacement therapy post heart transplant increases with worsening eGFR at listing even after adjusting for multiple confounders with the highest risk in the group with eGFR <30 ml/min. This information may help identify patients for combined heart-kidney transplant in a more reasonable time frame.

Risk of post heart transplant ESRD by listing eGFR
eGFR at time of listingESRD
N (%)
Adj hazard ratio with p valueMortality
N (%
Adj hazard ratio with p value
eGFR <30157 (21.7)2.77 (p<0.001)284 (39.6)1.10 (p=0.148)
eGFR 30-44572 (15.7)2.16 (p<0.001)1289 (35.5)1.11 (p<0.001)
eGFR 45-60617 (10.1)1.40 (p<0.001)1961 (32.4)1.05 (p=0.092)
eGFR > 60989 (7)14061 (28.9)1

Figure 1: Kaplan-Meier estimate for renal survival